Bone Biologics

Bone Biologics is a publicly traded company based in Burlington, Massachusetts, USA, focusing on the development and sale of orthopedic products. Bone Biologics' proprietary platform technology is NELL-1, a recombinant human protein growth factor that is crucial for normal bone development. The company's lead product is a NELL-1-based bone graft substitute for spinal fusion, targeting the rapidly growing orthopedic market. Bone Biologics aims to provide patients with greater safety and uncompromised efficacy compared to existing technologies. NELL-1 has been shown in both laboratory and animal studies to specifically regulate bone regeneration in the presence of osteoblasts, offering targeted control unlike any current therapy.